NCT05052645
Withdrawn
Not Applicable
Auricular Acupuncture in the Treatment of Neuropathic Pain: A Randomized Controlled Trial
ConditionsNeuropathic Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Neuropathic Pain
- Sponsor
- Mayo Clinic
- Locations
- 1
- Primary Endpoint
- Change in self-reported neuropathic pain scores
- Status
- Withdrawn
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to gather information on the effectiveness of auricular acupuncture (i.e., the placement of acupuncture needles in specific points on the ear) in reducing pain and improving quality of life among patients experiencing neuropathic pain in the acute inpatient rehabilitation setting.
Investigators
Tony Y. Chon
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Patients who have acute or chronic neuropathic pain of any etiology (traumatic, non-traumatic, central, peripheral, and mixed cases).
- •Ability to provide informed consent.
- •Ability to speak English and complete all aspects of this trial.
- •At least 18 years of age.
- •Patients will have stable neuropathic pain medication dosing for 3 days prior to enrollment to include gabapentin, pre-gabalin, TCAs, duloxetine, carbamazepine, oxcarbazepine, and venlafaxine).
Exclusion Criteria
- •Patients with platelet count \<50,000 or known bleeding disorder.
- •Patients in a severe immunocompromised state.
- •Pregnant women. All patients who meet the criteria will have their medical records reviewed to ensure they are not pregnant.
- •Allergy to gold.
- •Use of non-FDA approved herbal supplements. Their effect on enhancing or blunting effect of acupuncture is not known. Patients using medical marijuana with an approved prescription from a state issuing such prescriptions will not be excluded.
- •Current infection of the skin or cartilage of the ear.
- •Patients already using adjuvant modalities such as chiropractic, massage, yoga, tai chi, massage will not be excluded, but those who add in these modalities during the course of the intervention and observation period will be excluded.
- •Patients not anticipated to stay for a minimum of 7 days after enrollment.
- •Patient without mental capacity to participate in the consent process and the questionnaire responses.
- •Fear of needles or no interest in acupuncture.
Outcomes
Primary Outcomes
Change in self-reported neuropathic pain scores
Time Frame: Daily during inpatient stay, approximately 7-10 days
Measured on the numeric rating scale for pain (NRS Pain) for pain intensity using a scale of 0=no pain, 10=worst imaginable
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Early Phase 1
Acupuncture for Pain in the Emergency DepartmentMusculoskeletal PainPainNCT02540512Loma Linda University
Unknown
Phase 2
Effectiveness of Acupuncture for Phonotraumatic InjuriesPhonotraumatic InjuriesNCT00803582The University of Hong Kong135
Not yet recruiting
Phase 1
Efficacy evaluation of auricular acupuncture in the treatment of pregnancy nausea and vomiting: A protocol of randomized controlled trialTCTR20220627007Ya Zou43
Not yet recruiting
Phase 2
The Effect of Non-invasive Auricular Acupoint Stimulation on Slow Transmission ConstipationSlow Transmission ConstipationNCT06680882The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine60
Completed
Not Applicable
Ear Acupuncture for Pain and Anxiety Management in Early LaborPainAnxietyLaborNCT06678893Women and Infants Hospital of Rhode Island38